
| 2020 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| 2019 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| 2018 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | 600-700 |
| Total Number of Projects: | > 1000 |
| 2016 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 4
As coordinator: 0
As participant: 3
Sole participant: 1
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2019 | 0 | 5.660.096 | 300.000 | 1 | ||
| 2018 | 2.450.327 | 0 | 2.450.327 | 1 | ||
| 2017 | 0 | 2.998.500 | 344.164 | 1 | ||
| 2016 | 0 | 1.793.280 | 483.744 | 1 | ||
Total number of partners: 21
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 21
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2019-01-01 | Active aGeIng and Osteoporosis: The next challenge for smarT nanobiOmaterials and 3D technologies | GIOTTO | participant | 5.660.096 | 14 |
| 2018-09-01 | High Throughput Bioprinting of Tumour Models for Drug Development and Oncology Research | TUMOURPRINT | coordinator | 2.450.327 | 1 |
| 2017-11-01 | Genetically engineered human pluripotent stem cells, functionalized silk-fibroin platforms and bio-inks: a novel solution for large-scale ex-vivo platelet production, transfusion and drug research | SilkFUSION | participant | 2.998.500 | 6 |
| 2016-10-01 | Cell-Based Models for Neurodegeneration Study and Use in Screening | CENSUS | participant | 1.793.280 | 4 |